Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Special city council meeting called over leak of confidential Calgary budget docs

September 4, 2026

HP Announces New OmniBook PCs to Help Build the Next Generation of AI Experiences

September 4, 2026

Roland is getting into generative AI music with Melody Flip

September 4, 2026

Logistics Expert and Scholar Michael Curtis Broughton Publishes New Book THE SEAPORT EXECUTION SYSTEM

September 4, 2026

Spreadefi releases mobile app for iOS and Android

September 4, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033
Press Release

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

By News RoomFebruary 24, 20263 Mins Read
Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) — The “Personalized Medicine Market Companies Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts” report has been added to ResearchAndMarkets.com’s offering.

The global personalized medicine market was valued at around US$ 585.53 billion in 2026 and is anticipated to reach nearly US$ 1.00 trillion by 2033.

The personalized medicine market will see a CAGR of 7.05% from 2025 to 2033. This growth can be associated with advances in genomics and biotechnology, along with increasing demand for treatments tailored to improve therapeutic efficacy and reduce side effects.

Personalized medicine, which is also referred to as precision medicine, is an approach toward diagnosis and treatment that takes into consideration an individual’s unique genetic background, lifestyle, and environmental factors. Unlike the more conventional approaches, wherein treatment often involves one-size-fits-all remedies, the application of personalized medicine optimizes therapy by taking into consideration the characteristics of a particular patient and thus, in general, yields better outcomes with fewer side effects.

The popularity of personalized medicine has grown significantly across the world, particularly in view of developments in genomics and biotechnology. Due to the reduced cost of genetic sequencing and the budding sector of data analytics, health practitioners can now make more precise decisions for the particular condition affecting an individual. This shift has gained traction in areas such as oncology, where targeted therapies can vastly improve survival rates by focusing on specific mutations within tumors.

Besides this, increasing health and well-being awareness among people, along with active participation of patients, has created demand for therapies that can connect to them on a personal note. With continuous research and availability of more therapies, the role of personalized medicine will continue to increase globally in the years to come.

Key Attributes:

Report Attribute Details
No. of Pages 200
Forecast Period 2025 – 2033
Estimated Market Value (USD) in 2025 $585.53 Billion
Forecasted Market Value (USD) by 2033 $1000 Billion
Compound Annual Growth Rate 7.0%
Regions Covered Global

Key Topics Covered:

1. Personalized Medicine Market
1.1 Historical Trends
1.2 Forecast Analysis

2. Market Share Analysis – Personalized Medicine Market

3. Abbott Laboratories
3.1 Overview
3.1.1 Company History and Mission
3.1.2 Business Model and Operations
3.1.3 Workforce
3.2 Key Persons
3.2.1 Executive Leadership
3.2.2 Operational Management
3.2.3 Division Leaders
3.2.4 Board Composition
3.3 Recent Development & Strategies
3.3.1 Mergers & Acquisitions
3.3.2 Partnerships
3.3.3 Investments
3.4 Sustainability Analysis
3.4.1 Renewable Energy Adoption
3.4.2 Energy-Efficient Infrastructure
3.4.3 Use of Sustainable Packaging Materials
3.4.4 Water Usage and Conservation Strategies
3.4.5 Waste Management and Circular Economy Initiatives
3.5 Product Analysis
3.5.1 Product Profile
3.5.2 Quality Standards
3.5.3 Product Pipeline
3.5.4 Product Benchmarking
3.6 Strategic Assessment: SWOT Analysis
3.6.1 Strengths
3.6.2 Weaknesses
3.6.3 Opportunities
3.6.4 Threats
3.7 Revenue Analysis

Above Information Will Be Provided for All the Following Companies

  • Abbott Laboratories
  • GE Healthcare, Inc.
  • Aadi Bioscience, Inc.
  • Illumina, Inc.
  • QIAGEN
  • Eli Lilly and Company
  • Takeda Pharmaceutical Company Ltd
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Exact Sciences Corporation
  • Thermo Fisher Scientific Inc.
  • Novartis AG
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Biogen Inc.
  • Siemens Healthineers AG
  • Agilent Technologies, Inc.
  • Myriad Genetics, Inc.
  • Amgen Inc.

For more information about this report visit https://www.researchandmarkets.com/r/qg29df

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Personalized Medicine Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

HP Announces New OmniBook PCs to Help Build the Next Generation of AI Experiences

Logistics Expert and Scholar Michael Curtis Broughton Publishes New Book THE SEAPORT EXECUTION SYSTEM

Spreadefi releases mobile app for iOS and Android

Former Under Secretary of Defense Michèle Flournoy and Former USSOCOM Commander Admiral Eric T. Olson Join Spirit of America Board of Directors

XTransfer Secures In-Principle Approval for Retail Payment Services Licence from UAE Central Bank

After Tuiga it’s the turn of Malizia 4 to fly Yacht Club de Monaco’s flag high in New York

Blaze Pizza Boosts September Fundraising Giveback to 25% for Local Schools and Community Groups

UPDATE – OCJOY Debuts at IFA 2026: Bringing Clinic-Grade Oral Care Home

Funded Trader Markets Publishes Full Programme Specifications for Simulated Funding Accounts

Editors Picks

HP Announces New OmniBook PCs to Help Build the Next Generation of AI Experiences

September 4, 2026

Roland is getting into generative AI music with Melody Flip

September 4, 2026

Logistics Expert and Scholar Michael Curtis Broughton Publishes New Book THE SEAPORT EXECUTION SYSTEM

September 4, 2026

Spreadefi releases mobile app for iOS and Android

September 4, 2026

Latest News

Four sentenced in connection with killing of 19-year-old Burnaby man

September 4, 2026

Microsoft says virtually nobody was grabbing NYT articles through its chatbot

September 4, 2026

Former Under Secretary of Defense Michèle Flournoy and Former USSOCOM Commander Admiral Eric T. Olson Join Spirit of America Board of Directors

September 4, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version